Speak directly to the analyst to clarify any post sales queries you may have.
Clinical trial supply & logistics encompasses the planning, management, storage, and distribution of clinical trial materials (CTMs) needed to conduct clinical studies. These materials include investigational medicinal products (IMPs), placebos, patient kits, ancillary supplies, and labeling services. The main objective of CTSL is to ensure that clinical trials are conducted efficiently and in compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines while maintaining product quality and integrity. The prevalence of chronic disorders and increasing government investments in pharmaceutical research & development process drives the use of clinical trial supply & logistics. On the contrary, the cost-intensive nature of clinical trials and the limited availability of trained professionals hinders market growth. However, growing interest in drug development projects coupled with outsourcing clinical trials is expected to increase its usage in the coming years.
Regional Insights
In the Americas region, North America has considerable utilization of clinical trial supply & logistics, with the United States leading the growth with its robust pharmaceutical industry and extensive investment in research and development (R&D). Furthermore, numerous leading pharmaceutical companies conducting clinical trials and strong government support for R&D activities drive market expansion. South America also contributes to increasing clinical trial supply & logistics usage due to its developing healthcare infrastructure and growing focus on clinical research. The Asia-Pacific region’s clinical trial supply & logistics market is growing rapidly due to its rapidly evolving pharmaceutical industry in China, India, South Korea, Taiwan, Indonesia, and Vietnam, among others. Moreover, many multinational pharmaceutical companies have established their R&D centers or collaborations with local partners in this region due to resource availability at competitive prices. Within the EMEA region, Europe has been traditionally considered a stronghold for the global clinical trial supply & logistics market due to the presence of numerous pharmaceutical and biotechnology companies. The European Union (EU) has a well-established framework for conducting clinical trials across its member states that ensures the safety, efficacy, and quality of investigational medicinal products (IMPs). In addition, Middle East & Africa are emerging markets within the EMEA region due to increasing healthcare expenditure by governments, expansion of multinational pharmaceutical companies into these markets to tap a larger patient pool for testing their investigational drugs/devices, continuous development of healthcare infrastructure and availability of skilled workforce due to their investments in education.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supply & Logistics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supply & Logistics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Almac Group, Ancillare, LP, Beroe Holdings Inc., Biocair International Limited, Catalent, Inc., Clinigen Group PLC, COREX LOGISTICS LIMITED, Deutsche Post AG, Eurofins Scientific Group, ICON PLC, Inceptua S.A., Infosys Limited, KLIFO A/S, Liveo Research GmbH, Lonza Group AG, Marken Limited, Myonex, Inc., N-SIDE SA, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Solutions, SAP SE, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific, Inc., and Walden Group.Market Segmentation & Coverage
This research report categorizes the Clinical Trial Supply & Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:- Services
- Comparator Sourcing
- Logistics & Distribution
- Cold Chain Distribution
- Non-Cold Chain Distribution
- Manufacturing
- Packaging, Labeling, & Blinding
- Storage & Retention
- Type
- Biologic Drugs
- Medical Devices
- Small Molecules
- Phase
- BA/ BE studies
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Therapeutic Area
- Blood Disorders
- Cardiovascular Diseases
- CNS & Mental Disorders
- Dermatological Disorders
- Digestive Disorders
- ENT Diseases
- Immunology
- Infectious Diseases
- Metabolic Disorders
- Nephrology
- Oncology
- Rare Diseases
- Respiratory Disorders
- End User
- Contract Research Organisations (CROs)
- Medical Devices Companies
- Pharmaceutical & Biotechnology companies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as
- What is the market size and forecast of the Clinical Trial Supply & Logistics Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supply & Logistics Market?
- What are the technology trends and regulatory frameworks in the Clinical Trial Supply & Logistics Market?
- What is the market share of the leading vendors in the Clinical Trial Supply & Logistics Market?
- Which modes and strategic moves are suitable for entering the Clinical Trial Supply & Logistics Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
Companies Mentioned
- Almac Group
- Ancillare, LP
- Beroe Holdings Inc.
- Biocair International Limited
- Catalent, Inc.
- Clinigen Group PLC
- COREX LOGISTICS LIMITED
- Deutsche Post AG
- Eurofins Scientific Group
- ICON PLC
- Inceptua S.A.
- Infosys Limited
- KLIFO A/S
- Liveo Research GmbH
- Lonza Group AG
- Marken Limited
- Myonex, Inc.
- N-SIDE SA
- Octalsoft
- Parexel International Corporation
- PCI Pharma Services
- PHOENIX Pharmahandel GmbH & Co KG
- Piramal Pharma Solutions
- SAP SE
- Signant Health
- SIRO Clinpharm Private Limited
- Thermo Fisher Scientific, Inc.
- Walden Group
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 184 |
Published | March 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 24.33 Billion |
Forecasted Market Value ( USD | $ 41.04 Billion |
Compound Annual Growth Rate | 7.7% |
Regions Covered | Global |
No. of Companies Mentioned | 28 |